AIMD Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeP/E ratio—Forward 13.91
EPS (TTM)$-2.830.0% YoY
Profit margin0.0%TECHNOLOGY
Market cap$13.6MMicro cap
Valuation
- Forward P/E
- 13.91
- PEG ratio
- 0.93
- P/B
- 2.38
- P/S (TTM)
- 748.21
- EV/EBITDA
- -1.60
Profitability & growth
- ROE (TTM)
- -148.2%
- Operating margin
- -1418414.0%
- Revenue growth YoY
- -99.8%
- Dividend yield
- —
- Beta
- 2.43
Last earnings
Nov 13, 2025 · Estimate $0.00 · Reported $-0.64
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Ainos Inc
Company profileAinos, Inc., a healthcare company, is dedicated to the development of medical technologies for safe and novel point-of-care testing and medical treatment for disease indications. The company is headquartered in San Diego, California.
Classification
- Sector
- Technology
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 3050 POST OAK BOULEVARD, HOUSTON, TX
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$13.6M
Shares outstanding$7.4M
52W high$4.50
52W low$1.26
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent